Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Maculopathies,Age-related”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT02130531
What this trial is testing

Pharmacokinetic and Pharmacodynamic Study of Emixustat in Subjects With Geographic Atrophy Associated With Dry Age-Related Macular Degeneration

Who this might be right for
Geographic AtrophyAge-Related Macular Degeneration
Kubota Vision Inc. 26
Testing effectiveness (Phase 2)Ended earlyNCT01674829
What this trial is testing

A PhaseI/IIa Study to Determine the Safety and Tolerability of MA09-hRPE Cells in Patients With Advanced Dry AMD

Who this might be right for
Dry Age Related Macular Degeneration
CHABiotech CO., Ltd 10
Very early researchUnknownNCT05099094
What this trial is testing

VEGFA-targeting Gene Therapy to Treat Retinal and Choroidal Neovascularization Diseases

Who this might be right for
Neovascular Age-related Macular DegenerationDiabetic Macular EdemaRetinal Vein Occlusion
Shanghai BDgene Co., Ltd. 3
Not applicableStudy completedNCT01918553
What this trial is testing

Cohort Study on the Age-related Macular Degeneration: Incidence and Research for Predisposing Factors

Who this might be right for
Elderly French PopulationAge-related Macular Degeneration
University Hospital, Bordeaux 516
Not applicableStudy completedNCT05441072
What this trial is testing

Validation of Bulbicam for DR- and AMD-patients

Who this might be right for
Diabetic RetinopathyAge-Related Macular Degeneration
Meddoc 64
Early research (Phase 1)Study completedNCT04151212
What this trial is testing

A Phase I Clinical Trial of BAT5906 Injection in Patients With Wet Age-related Macular Degeneration

Who this might be right for
Age-related Macular Degeneration
Bio-Thera Solutions 24
Testing effectiveness (Phase 2)Study completedNCT00531336
What this trial is testing

MAAM Study: Avastin and Macugen Versus Avastin Versus Macugen

Who this might be right for
Macular Degeneration
The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery 60
Not applicableEnded earlyNCT00474695
What this trial is testing

Study Evaluating Genotypes Using Lucentis

Who this might be right for
Age-Related Maculopathy
University of Utah 65
Post-approval studies (Phase 4)Study completedNCT01148511
What this trial is testing

Comparison of Safety, Effectiveness and Quality of Life Outcomes Between Labeled Versus "Treat and Extend" Regimen in Turkish Patients With Choroidal Neovascularisation Due to Age-related Macular Degeneration (AMD)

Who this might be right for
Age-related Macular Degeneration
Novartis Pharmaceuticals 99
Early research (Phase 1)Study completedNCT00782093
What this trial is testing

Ascending and Parallel Group Trial to Establish the Safety, Tolerability and Pharmacokinetics Profile of Volociximab (Alpha 5 Beta 1 Integrin Antagonist) in Subjects With Neovascular Age- Related Macular Degeneration

Who this might be right for
Age-related Macular Degeneration
Ophthotech Corporation 63
Post-approval studies (Phase 4)Study completedNCT00680498
What this trial is testing

Combination Lucentis and Ocular Photodynamic Therapy With Visudyne, With Evaluation-based Retreatment

Who this might be right for
Age-Related Macular Degeneration
Illinois Retina Associates 10
Not applicableEnrolling By InvitationNCT01757132
What this trial is testing

Post-Approval Study of the Implantable Miniature Telescope

Who this might be right for
AMD
VisionCare, Inc. 770
Post-approval studies (Phase 4)Study completedNCT02257632
What this trial is testing

Systemic Vascular Endothelial Growth Factor (VEGF) Protein Dynamics Following Intravitreal Injections of Ranibizumab Versus Aflibercept in Patients With Neovascular Age-related Macular Degeneration

Who this might be right for
Wet Age-Related Macular Degeneration
Novartis Pharmaceuticals 41
Testing effectiveness (Phase 2)UnknownNCT05187104
What this trial is testing

Treatment of Age-related Macular Degeneration Using Retinal Stem and Progenitor Cells

Who this might be right for
Age-Related Macular Degeneration
Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus 20
Testing effectiveness (Phase 2)Study completedNCT03197493
What this trial is testing

Extension, Carbidopa-levodopa in Neovascular Age-related Macular Degeneration (AMD)

Who this might be right for
Macula; DegenerationRetina
Snyder, Robert W., M.D., Ph.D., P.C. 35
Not applicableStudy completedNCT01103505
What this trial is testing

HOme Vision Monitoring in AREDS2 for Progression to Neovascular AMD Using the ForeseeHome Device

Who this might be right for
Age Related Macular Degeneration
Notal Vision Ltd. 1,520
Testing effectiveness (Phase 2)Study completedNCT00413829
What this trial is testing

Immediate Effects of Lucentis® in Conjunction With Photodynamic Therapy With Visudyne® in Exudative AMD(IECOMB)

Who this might be right for
Age Related Macular Degeneration
Insel Gruppe AG, University Hospital Bern 20
Large-scale testing (Phase 3)Study completedNCT00051129
What this trial is testing

Anecortave Acetate in Subfoveal Choroidal Neovascularization (CNV) Due to Wet Age-Related Macular Degeneration (AMD)

Who this might be right for
Macular DegenerationMaculopathy, Age-RelatedAge-Related Maculopathies+2 more
Alcon Research 291
Not applicableStudy completedNCT00787319
What this trial is testing

Long-Term Non-Interventional Study (NIS) To Investigate The Safety And Effectiveness Of MACUGEN In Patients With Neovascular Age-Related Macular Degeneration Under Conditions Of Routine Clinical Practice

Who this might be right for
Age-related Macular Degeneration
Pfizer 108
Testing effectiveness (Phase 2)Study completedNCT05275205
What this trial is testing

Safety, Tolerability, and Efficacy Study of UBX1325 in Patients With Neovascular Age-Related Macular Degeneration (ENVISION)

Who this might be right for
Neovascular Age-related Macular Degeneration
Unity Biotechnology, Inc. 51
Next Page